Relating to scheduling of thiafentanil.
Submitted by the Controlled Substances Board .
hist68299Report received from Agency, April 19, 2017.
hist69453Referred to the committee on Judiciary and Public Safety, May 3, 2017.
Relating to scheduling of AB-FUBINACA and ADB-PINACA.
Submitted by the Controlled Substances Board .
hist68298Report received from Agency, April 19, 2017.
hist69454Referred to the committee on Judiciary and Public Safety, May 3, 2017.
Relating to scheduling of brivaracetam.
Submitted by the Controlled Substances Board .
hist68300Report received from Agency, April 19, 2017.
hist69455Referred to the committee on Judiciary and Public Safety, May 3, 2017.
_____________
Messages from the Assembly
By Patrick E. Fuller, chief clerk.
Mr. President:
I am directed to inform you that the Assembly has adopted and asks concurrence in:
hist69412Assembly Joint Resolution 18
Passed and asks concurrence in:
hist69432Assembly Bill 25
hist69433Assembly Bill 58
hist69434Assembly Bill 115
hist69435Assembly Bill 116
hist69436Assembly Bill 123
hist69437Assembly Bill 125
hist69438Assembly Bill 138
hist69439Assembly Bill 160
hist69411Assembly Bill 194
hist69440Assembly Bill 233
hist69441Assembly Bill 234
hist69442Assembly Bill 235
hist69443Assembly Bill 236
hist69444Assembly Bill 237
Concurred in:
hist69428Senate Bill 62
hist69429Senate Bill 76
hist69413Senate Joint Resolution 16
hist69414Senate Joint Resolution 17
hist69415Senate Joint Resolution 20
hist69416Senate Joint Resolution 30
hist69417Senate Joint Resolution 33
hist69418Senate Joint Resolution 41
hist69419Senate Joint Resolution 43
hist69420Senate Joint Resolution 45
hist69421Senate Joint Resolution 46
Loading...
Loading...